Procedures, dossier requirements, pharmacovigilance, policy
Marketing authorisation, reporting adverse events, production, distribution
Our story, our work, the organisation, working at the MEB, contact
21-12-2020 | 10:00
Due to security precautions, the MEB has had to switch off the DCP time slot planning tool.
17-12-2020 | 17:00
Earlier the Medicines Evaluation Board announced the next MEB Science Day ‘The evolution of 25 years of Pharmacovigilance’ on 18 ...
19-10-2020 | 17:00
The eleventh edition of the MEB’s Regulatory Science Magazine brings you interviews with Peter Mol, professor of Drug Regulatory ...
01-09-2020 | 09:00
Requests to withdraw marketing authorisations and parallel import marketing authorisations as of 31 December 2020, the so-called ...
26-08-2020 | 10:00
Patients and consumers can continue to use paracetamol safely in the Netherlands. This is the conclusion of the Netherlands ...
09-07-2020 | 22:30
Tonight (Thursday July 9) the Dutch newspaper NRC and TV programme Zembla published an article on contamination of paracetamol ...